Stock research
NMRD Nemaura Medical Inc.
Healthcare • Medical - Devices
Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invasive continuous...…
Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invasive continuous glucose monitoring (CGM) system. This device is designed to assist individuals with Type 1 and Type 2 diabetes in managing their condition, and it can also screen for pre-diabetic states. Beyond this, Nemaura offers proBEAT, a wellness guidance service that delivers educational prompts to users about factors influencing their blood sugar profiles. The company also conducts specialized programs aimed at diabetes prevention and reversal. Established in 2009, Nemaura Medical Inc. operates from its headquarters in New York City.
5Y change
-100.00%
Range high
$7.64
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in NMRD?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $0.00
- Day High
- $0.00
- Day Low
- $0.00
- 52w High
- $0.00
- 52w Low
- $0.00
- Volume
- 500
- Avg Volume
- Beta
- 0.923
* TTM/most recent where available
Company
- Ticker
- NMRD
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
- CEO
- Dewan Fazlul Hoque Chowdhury
- Employees
- 36
- Website
- nemauramedical.com
Key Metrics
- Market Cap
- 4.04K
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).